Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Khvorova; Anastasia
Address:
Boulder, CO
No. of patents:
30
Patents:




Patent Number Title Of Patent Date Issued
7619081 siRNA targeting coatomer protein complex, subunit beta 2 (COPB2) November 17, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits
7615541 siRNA targeting TIE-2 November 10, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits
7612196 siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B) November 3, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits
7608707 siRNA targeting survivin October 27, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes.
7608706 siRNA targeting ras-related nuclear protein October 27, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits
7605252 siRNA targeting kinase insert domain receptor (KDR) October 20, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits
7605250 siRNA targeting cAMP-specific phosphodiesterase 4D October 20, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits
7598370 siRNA targeting polo-like kinase-1 (PLK-1) October 6, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits
7598369 siRNA targeting histamine receptor H1 October 6, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits
7595389 siRNA targeting casitas B cell lymphoma-B (CBL-B) September 29, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits
7595388 siRNA targeting EPH receptor A3 (EPHA3) September 29, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits
7595387 Modified polynucleotides for reducing off-target effects in RNA interference September 29, 2009
Methods and compositions for performing RNA interference with decreased off-target effects are provided The methods and compositions permit effective and efficient applications of RNA interference to applications such as diagnostics and therapeutics through the use of modifications to
7592444 siRNA targeting myeloid cell leukemia sequence 1 September 22, 2009
Efficient sequence specific gene silencing of myeloid cell leukemia sequence 1 is possible through the use of siRNA technology. By selecting particular siRNAs directed to myeloid cell leukemia sequence 1 by rationale design, one can maximize the generation of an effective gene silenc
7592443 siRNA targeting interleukin-1 receptor-associated kinase 4 (IRAK4) September 22, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits
7592442 siRNA targeting ribonucleotide reductase M2 polypeptide (RRM2 or RNR-R2) September 22, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits
7589191 siRNA targeting hypoxia-inducible factor 1 September 15, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits
7582747 siRNA targeting inner centromere protein antigens (INCENP) September 1, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits
7582746 siRNA targeting complement component 3 (C3) September 1, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits
7579458 siRNA targeting synuclein, alpha (SNCA-1) August 25, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits
7579457 siRNA targeting carbonic anhydrase II August 25, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes.
7576197 SiRNA targeting KRAS August 18, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs directed to silencing KRAS, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes.
7576196 siRNA targeting transducin (beta)-like 3 (TBL3) August 18, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits
7569684 siRNA targeting gremlin August 4, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits
7550572 siRNA targeting cell division cycle 20 homolog (CDC20) June 23, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits
7541453 siRNA targeting aquaporin 4 June 2, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits
7521191 siRNA targeting connexin 43 April 21, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits
7514550 siRNA targeting myeloid cell leukemia sequence 1 April 7, 2009
Efficient sequence specific gene silencing of myeloid cell leukemia sequence 1 is possible through the use of siRNA technology. By selecting particular siRNAs directed to myeloid cell leukemia sequence 1 by rationale design, one can maximize the generation of an effective gene silenc
7511132 Functional and hyperfunctional siRNA directed against Bcl-2 March 31, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing Bcl-2.
7507811 siRNA targeting KRAS March 24, 2009
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rationale design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes.
6225063 RNA channels in biological membranes May 1, 2001
The present invention provides nucleic acid molecules capable of binding phospholipid membranes, and more particularly RNA molecules capable of binding and forming channels in biological membranes. In this regard the present invention provides methods for screening nucleic acid molecules


 
 
  Recently Added Patents
Interface device with network isolation
System and method for directional prefetching
Bias correcting phase compensating rate limiter
Bottle
Method and system for crosstalk cancellation
System and method for filtering and organizing items based on common elements
Flexible bookmark
  Randomly Featured Patents
Prober apparatus
Facility inspection support apparatus
Beverage container with bottom cavity
Geranium plant named `Dueamica`
Document stacker apparatus and method of stacking documents
End plate incorporated in battery power source unit
Auto suction hybrid pump
Biopsy forceps having a detachable proximal handle and distal jaws
Surface configuration of a front bumper for a vehicle
Soybean cultivar 010007